Travis Manni

What if Hollywood blockbusters included more characters with diabetes?

The two companies hope to create a new diabetes device.

Insulet touts improved OmniPod manufacturing standards just as FDA details summer recall notice of the pumps.

The nPOD program seeks to study the pancreases of people with diabetes.

Finding may make islet cell transplantation a more viable therapy for Type 1 diabetes.

The Dexcom G5 Mobile CGM gets the green light by the FDA to beam blood glucose readings directly to smartphones.

Younger kids who care for pets appear to manage their diabetes better.

If anyone can improve on Dexcom’s popular CGM design, it would be Google.

A Minnesota school district denies a student’s enrollment in their summer program because of his diabetes.

Socioeconomics doesn’t explain it, researchers say.

Medtronic says it could give inaccurate bolus suggestions, and the FDA takes action on the device, which is only sold…

Researchers find a preliminary connection between a mother’s blood sugar levels and a child’s academic success.

The study will test whether a common blood pressure medication can stop Type 1 shortly after diagnosis.

A Swedish study finds biologic markers in young children that predicts a future Type 1 diagnosis.

A study found that online interactions with doctors were as effective as office visits in kids with diabetes on pump…

An Insulin Nation reporter who does not have diabetes learns to appreciate his pancreas, and the everyday bravery of those…

The Diabetes Research Connection steers crowdfunding to younger scientists with innovative ideas.

We examine four internet diabetes “breakthrough” treatments, from superfruits to luxury spas.

A leading diabetes doctor documents how hospitals fail to protect the health of patients with diabetes.

Researchers give the insulin to children at high risk of Type 1 to teach their immune systems not to overreact.